Zou; Daozhong

Patent Applications and Registrations

Patent applications and USPTO patent grants for Zou; Daozhong.The latest application filed is for "forms and compositions of a mk2 inhibitor".

Company Profile

4.15.15

Zou; Daozhong - Raritan NJ
Zou; Daozhong - Bridgewater NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Solid forms comprising an oxime ether compound and a coformer, compositions and methods of use thereof Grant 11,434,200 - Huang , et al. September 6, 2	2022-09-06
Salts of a thiazolidinone compound, solid forms, compositions and methods of use thereof Grant 11,186,556 - Huang , et al. November 30, 2	2021-11-30
Forms And Compositions Of A Mk2 Inhibitor App 20210198276 - Han; Jianxin ; et al.	2021-07-01
Solid forms of a thiazolidinone compound, compositions and methods of use thereof Grant 11,013,723 - Huang , et al. May 25, 2	2021-05-25
Solid forms comprising a thiazolidinone compound, compositions and methods of use thereof Grant 11,014,897 - Huang , et al. May 25, 2	2021-05-25
Solid Forms Comprising an Oxime Ether Compound and a Coformer, Compositions and Methods of Use Thereof App 20210139420 - Huang; Lianfeng ; et al.	2021-05-13
Forms and compositions of a MK2 inhibitor Grant 10,882,867 - Han , et al. January 5, 2	2021-01-05
Solid Forms Comprising an Oxime Ether Compound, Compositions and Methods of Use Thereof App 20200399213 - Huang; Lianfeng ; et al.	2020-12-24
Solid Forms Comprising An Oxime Ether Compound, Compositions and Methods of Use Thereof App 20200377454 - Huang; Lianfeng ; et al.	2020-12-03
Forms And Compositions Of A Mk2 Inhibitor App 20200148701 - Han; Jianxin ; et al.	2020-05-14
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyri- midine-5-carboxamide Grant 10,590,089 - Boersen , et al.	2020-03-17
Forms and compositions of an ERK inhibitor Grant 10,202,364 - Ferretti , et al. Feb	2019-02-12
Formulations Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide App 20190031619 - BOERSEN; Nathan Andrew ; et al.	2019-01-31
Forms And Compositions Of An Erk Inhibitor App 20180362498 - Ferretti; Antonio Christian ; et al.	2018-12-20
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4methylcyclohexylamino)-pyrim- idine-5-carboxamide Grant 10,131,639 - Boersen , et al. November 20, 2	2018-11-20
Solid Forms Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione, And Their Pharmaceutical Compositions And Uses App 20180258064 - Huang; Lianfeng ; et al.	2018-09-13
Formulations of 3-(5-amino-2-methyl-4-oxo-4H-quinazolin-3-yl)-piperidine-2,6-dione Grant 10,064,863 - Walters , et al. September 4, 2	2018-09-04
Forms and compositions of an ERK inhibitor Grant 10,005,760 - Ferretti , et al. June 26, 2	2018-06-26
Formulations Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide App 20180009765 - BOERSEN; Nathan Andrew ; et al.	2018-01-11
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyri- midine-5-carboxamide, compositions thereof and methods of their use Grant 9,814,713 - Man , et al. November 14, 2	2017-11-14
Formulations of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-Methylcyclohexylamino)-pyri- midine-5-carboxamide Grant 9,796,685 - Boersen , et al. October 24, 2	2017-10-24
Forms And Compositions Of An Erk Inhibitor App 20170226083 - Ferretti; Antonio Christian ; et al.	2017-08-10
Formulations Of 3-(5-amino-2-methyl-4-oxo-4h-quinazolin-3-yl)-piperidine-2,6-dione App 20170056323 - Walters; Colin ; et al.	2017-03-02
Solid Forms Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide, Compositions Thereof And Methods Of Their Use App 20160256459 - Man; Hon-Wah ; et al.	2016-09-08
Formulations Of 2-(tert-butylamino)-4-((1r,3r,4r)-3-hydroxy-4-methylcyclohexylamino)-pyri- Midine-5-carboxamide App 20160168105 - BOERSEN; Nathan Andrew ; et al.	2016-06-16
Solid forms of 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyri- midine-5-carboxamide, compositions thereof and methods of their use Grant 9,365,524 - Man , et al. June 14, 2	2016-06-14
Crystalline form of the compound A-348441 Grant 8,124,129 - Cink , et al. February 28, 2	2012-02-28
Fused bicycloheterocycle substituted quinuclidine derivatives Grant 7,655,657 - Stoner , et al. February 2, 2	2010-02-02
Crystalline Form of the Compound A-348441 App 20090176754 - Cink; Russell Drew ; et al.	2009-07-09
Fused bicycloheterocycle substituted quinuclidine derivatives App 20080064703 - Stoner; Eric J. ; et al.	2008-03-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.